Advertisement
News
Advertisement

Satori socks away $7M in new $20M funding

Tue, 01/04/2011 - 4:35am
Mass High Tech: The Journal of New England Technology

Satori Pharmaceuticals Inc., a Cambridge-based developer of drugs for neurodegenerative disorders, has raised $7 million in a new round of financing that is targeting $20 million, according to federal documents.

If the full $20 million is raised, the latest financing brings Satori, which was founded in 2004, to a total of almost $46 million in funding, including its $22 million Series A round in 2007.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading